Cancer medicines
Degarelix
Degarelix
A GnRH antagonist lowering testosterone in prostate cancer.
Sources checked · Introductory guide
On this page
How it works
It blocks GnRH receptors to suppress androgen production.[3]
Where it is used
Used for androgen deprivation in advanced prostate cancer. It acts differently from GnRH agonists.[1]
Key safety points
Discuss injection-site reactions and bone health. Disclose rhythm problems and medicines; fainting, palpitations or breathlessness need urgent assessment.[2]
Questions for your care team
- Why was this drug chosen, and when are PSA and testosterone checked?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Degarelix (opens in a new tab)
- MedlinePlus · Degarelix (opens in a new tab)
- NCI Drug Dictionary · Degarelix (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.